Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Mahner

Showing results (371-380 of 455) with videos related to

Pageof 46
Sort By:
Cancers|September 9, 2020
Definition and Independent Validation of a Proteomic-Classifier in Ovarian CancerSabine Kasimir-Bauer, Joanna Roder, Eva Obermayr, et al.
Histopathology|July 15, 2018
Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survivalSilvia Darb-Esfahani, Ivonne Kolaschinski, Fabian Trillsch, et al.
Gynecologic Oncology Research and Practice|March 14, 2017
Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trialRadoslav Chekerov, Philipp Harter, Stefan Fuxius, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 17, 2020
LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trialAnnette Hasenburg, Jalid Sehouli, Bjoern Lampe, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2013
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortiumDietmar Pils, Anna Bachmayr-Heyda, Katharina Auer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 30, 2020
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 studyRudiger Klapdor, Peter Hillemanns, Linn Wölber, et al.
BMC Genomics|August 17, 2016
AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancerMartin Svoboda, Anastasia Meshcheryakova, Georg Heinze, et al.
Psycho-Oncology|February 23, 2016
Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES studyVarinka Voigt, Franziska Neufeld, Judith Kaste, et al.
Journal of Cancer Research and Clinical Oncology|March 31, 2023
Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ)Radoslav Chekerov, Tjadina Arndt, Klaus Pietzner, et al.
Cancers|August 7, 2021
Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance DevelopmentTabea L Bauer, Katrin Collmar, Till Kaltofen, et al.
Pageof 46

Showing results (371-380 of 455) with videos related to

Sort By:
Pageof 46
Cancers|September 9, 2020
Definition and Independent Validation of a Proteomic-Classifier in Ovarian CancerSabine Kasimir-Bauer, Joanna Roder, Eva Obermayr, et al.
Histopathology|July 15, 2018
Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survivalSilvia Darb-Esfahani, Ivonne Kolaschinski, Fabian Trillsch, et al.
Gynecologic Oncology Research and Practice|March 14, 2017
Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trialRadoslav Chekerov, Philipp Harter, Stefan Fuxius, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 17, 2020
LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trialAnnette Hasenburg, Jalid Sehouli, Bjoern Lampe, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2013
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortiumDietmar Pils, Anna Bachmayr-Heyda, Katharina Auer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 30, 2020
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 studyRudiger Klapdor, Peter Hillemanns, Linn Wölber, et al.
BMC Genomics|August 17, 2016
AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancerMartin Svoboda, Anastasia Meshcheryakova, Georg Heinze, et al.
Psycho-Oncology|February 23, 2016
Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES studyVarinka Voigt, Franziska Neufeld, Judith Kaste, et al.
Journal of Cancer Research and Clinical Oncology|March 31, 2023
Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ)Radoslav Chekerov, Tjadina Arndt, Klaus Pietzner, et al.
Cancers|August 7, 2021
Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance DevelopmentTabea L Bauer, Katrin Collmar, Till Kaltofen, et al.
Pageof 46